Edition:
United Kingdom

Regenxbio Inc (RGNX.OQ)

RGNX.OQ on NASDAQ Stock Exchange Global Select Market

29.25USD
15 Dec 2017
Change (% chg)

$1.10 (+3.91%)
Prev Close
$28.15
Open
$28.20
Day's High
$29.80
Day's Low
$28.00
Volume
510,861
Avg. Vol
93,285
52-wk High
$35.95
52-wk Low
$16.30

Select another date:

Wed, Nov 8 2017

BRIEF-Regenxbio reports third quarter financial results

* Regenxbio reports third quarter 2017 financial results and recent operational highlights

BRIEF-RTW Investments reports 5 pct passive stake in Regenxbio

* RTW Investments reports a 5 percent passive stake in Regenxbio Inc as of October 2, 2017 - SEC filing Source text for Eikon: (http://bit.ly/2xkVMYD) Further company coverage:

BRIEF-Regenxbio announces completion of dosing of first cohort in Phase I clinical trial of RGX-314 gene therapy for wet AMD

* Regenxbio announces completion of dosing of first cohort in Phase I clinical trial of RGX-314 gene therapy for wet AMD

BRIEF-Dimension Therapeutics says co's board determined proposal from Ultragenyx Pharmaceutical could reasonably be expected to lead to "superior proposal"​

* Dimension Therapeutics - ‍Dimension board determines proposal from Ultragenyx Pharmaceutical could reasonably be expected to lead to "superior proposal"​

BRIEF-Regenxbio to acquire Dimension Therapeutics

* Dimension Therapeutics Inc says ‍boards of directors of both companies have unanimously approved transaction​

Select another date: